Cancer research at Duke is an interactive and dynamic enterprise that spans the School of Medicine and includes other Duke schools. Eleven major research programs have significant peer-reviewed funding and are operationally supported by DCCI administration and communication activities. The DCCI serves this central role, which helps to facilitate interprogrammatic as well as intraprogrammatic interactions of the research program members. In addition, exciting discoveries are identified early by the DCCI and are supported to facilitate entry into the pre-clinical development pathways and to their eventual use in clinical trials. In addition, the ability of investigators to take observations in the clinic back to the laboratory is facilitated by the DCCI. The DCCI is central to the complex coordination of activities essential to contemporary cancer research and makes possible many activities that would be far too complex to organize without the support of the CCSG. The DCCI was recently reorganized to have institute status at Duke. The DCCI differs from the former DCCC because it incorporates newly added institutional resources and infrastructure provided by significant investments in clinical trials support, as well as recognizes the oversight provided to specific components of departments and the health system. The formal institute status at Duke enhances communication and cooperation among the basic science departments with a significant focus on cancer and both the in-patient and out-patient cancer clinical services. The former Institutional Steering Committee, now named the Cancer Medicine Leadership Council (CMLC), has representatives from all of the relevant Duke clinical and research units (health system, hospital, departments, centers and institutes). All major strategic and operational decisions (e.g. expansion of clinical or research faculty within any of these units; capital investments in facilities or instrumentation; leadership appointments) that fall within the current scope of authority of any of these entities are presented and discussed within this council. Because of the significant administrative changes implemented in the past year, we have refrained for implementing our formal strategic planning until approval of the institute status of the DCCI. We are currently engaged in a strategic planning process being led by Elaine Kuttner of Cambridge Concord Associates and will have our Strategic Plan draft available at the time of the CCSG site visit.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014236-38S1
Application #
8532200
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-01-01
Budget End
2012-12-31
Support Year
38
Fiscal Year
2012
Total Cost
$2,501
Indirect Cost
$908
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Galaz-Montoya, Monica; Wright, Sara J; Rodriguez, Gustavo J et al. (2017) ?2-Adrenergic receptor activation mobilizes intracellular calcium via a non-canonical cAMP-independent signaling pathway. J Biol Chem 292:9967-9974
Lanier, Megan L; Park, Hyeri; Mukherjee, Paramita et al. (2017) Formal Synthesis of (+)-Laurencin by Gold(I)-Catalyzed Intramolecular Dehydrative Alkoxylation. Chemistry 23:7180-7184
Shi, Qiong; Liu, Hongliang; Han, Peng et al. (2017) Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol 137:1749-1756
Woyach, Jennifer A; Ruppert, Amy S; Guinn, Daphne et al. (2017) BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. J Clin Oncol 35:1437-1443
Wang, Yanru; Freedman, Jennifer A; Liu, Hongliang et al. (2017) Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer 141:731-743
Fayanju, Oluwadamilola M; Hall, Carolyn S; Bauldry, Jessica Bowman et al. (2017) Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg 214:666-671
Leu, David; Spasojevic, Ivan; Nguyen, Huy et al. (2017) CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5. Redox Biol 12:864-871
Sauer, Scott J; Tarpley, Michael; Shah, Imran et al. (2017) Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis 38:252-260
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Yin, Jieyun; Liu, Hongliang; Liu, Zhensheng et al. (2017) Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Mol Carcinog 56:1663-1672

Showing the most recent 10 out of 480 publications